Ezrin-Dependent Promotion of Glioma Cell Clonogenicity, Motility, and Invasion Mediated by BCL-2 and Transforming Growth Factor-β2

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Fig. 3.
Fig. 3.

Dominant-negative ezrin-induced inhibition of migration and invasion: association with altered BCL-2/BAX rheostat, decreased MMP activity, and decreased αvβ3integrin expression. A, The levels of BCL-2, BCL-XL, and BAX in LN-229 whole-cell lysates and of MMP-2, MMP-9, MT1-MMP, and TIMP-2 in the supernatant were examined by immunoblot. MMP-2 activity in conditioned medium of neo, nter-ezrin-, and F353-ezrin-transfected LN-229 cells was examined by gelatin zymography. All blots are representative of experiments performed three times with similar results. B,αvβ3 and α5β1integrin expression were determined by flow cytometry. The curves for αVβ3 antibody (bold line) and control antibody (dotted line) are shown. As documented in the bottom panel, there was no change in α5β1 integrin. In the bar graph, data are expressed as mean SFI values (n = 3).

  1. The Journal of Neuroscience vol. 21 no. 10 3360-3368
Responses to This Article
Be the first to respond to this article
Advertisement